NASDAQ:ALNY · Health Technology
Alnylam Pharmaceuticals, Inc.
$237.10▲ +0.2%Prices by TradingView · at least 15 min delayed
- Market cap
- $31.7B
- P/E (TTM)
- 40.0
- Dividend yield
- —
- 1y performance
- -47.5%
- YTD performance
- -40.6%
- 52-week range
- $197.81 – $495.55
- Currency
- USD
- Exchange
- NASDAQ
Held by these funds
issuer-published weights · 3 covered fundsFundWeight
iShs-MSCI World UCITS ETF Registered Shares USD (Dist)oN0.04%iShares Core MSCI World UCITS ETFS0.04%iShares MSCI ACWI0.04%Prices by TradingView, at least 15 minutes delayed. Fund weights are issuer-published. This is information, not advice.